Role of Cytokines in the Pathogenesis of Visceral Leishmaniasis

被引:11
作者
Kumar, Ramesh [1 ]
Bhatia, Madhav [2 ]
Pai, Kalpana [3 ]
机构
[1] Bundelkhand Univ, Dept Biochem, Jhansi 284128, UP, India
[2] Univ Otago, Dept Pathol, Christchurch, New Zealand
[3] Savitribai Phule Pune Univ, Dept Zool, Pune, Maharashtra, India
关键词
visceral leishmaniasis; cytokines; Th1; Th2; Th9; Th17; regulatory T cells; TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA; TGF-BETA; DISEASE PROGRESSION; DONOVANI INFECTION; CUTTING EDGE; HOST-DEFENSE; IFN-GAMMA; KALA-AZAR; CELLS;
D O I
10.7754/Clin.Lab.2017.170404
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Infection in humans with Leishmania manifests into a spectrum of diseases. The manifestations of the disease depend on the resultant evasion of the parasite to immune responses namely macrophages, which is an exclusive host of leishmania. The B cells valiantly mount antibody responses, however to no avail as the Leishmania parasites occupy the intracellular niches of the macrophages. Extensive studies have been documented on the role of cell-mediated immunity (CMI) in protection and counter survival strategies of the parasites leading to down-regulation of CMI. The present review attempts to discuss the cytokines in progression or resolution of visceral form of leishmaniasis or kala-azar, predominantly affecting the Indian subcontinent. The components/cytokine(s) responsible for the regulation of the critical balance of Th1/Th2/Th9/Th17/Treg cells has been discussed in the perspective. Therefore, any strategy involving the treatment of VL needs to consider the balance and regulation of CD4+ T cell function.
引用
收藏
页码:1549 / 1559
页数:11
相关论文
共 65 条
  • [1] Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO
  • [2] 2-Q
  • [3] TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
    Amadi-Obi, Ahjoku
    Yu, Cheng-Rong
    Liu, Xuebin
    Mahdi, Rashid M.
    Clarke, Grace Levy
    Nussenblatt, Robert B.
    Gery, Igal
    Lee, Yun Sang
    Egwuagu, Charles E.
    [J]. NATURE MEDICINE, 2007, 13 (06) : 711 - 718
  • [4] IL-27 and IL-21 Are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis
    Ansari, Nasim Akhtar
    Kumar, Rajiv
    Gautam, Shalini
    Nylen, Susanne
    Singh, Om Prakash
    Sundar, Shyam
    Sacks, David
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186 (07) : 3977 - 3985
  • [5] IL-9 is a susceptibility factor in leishmania major infection by promoting detrimental Th2/type 2 responses
    Arendse, B
    van Snick, J
    Brombacher, F
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (04) : 2205 - 2211
  • [6] Cutting edge:: Early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection
    Artis, D
    Johnson, LM
    Joyce, K
    Saris, C
    Villarino, A
    Hunter, CA
    Scott, P
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (08) : 4672 - 4675
  • [7] Interleukin 17 Production among Patients with American Cutaneous Leishmaniasis
    Bacellar, Olivia
    Faria, Daniela
    Nascimento, Marcia
    Cardoso, Thiago M.
    Gollob, Kenneth J.
    Dutra, Walderez O.
    Scott, Phillip
    Carvalho, Edgar M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (01) : 75 - 78
  • [8] INTERLEUKIN-6 ANTAGONIZES TUMOR NECROSIS FACTOR-MEDIATED MYCOBACTERIOSTATIC AND MYCOBACTERIOCIDAL ACTIVITIES IN MACROPHAGES
    BERMUDEZ, LE
    WU, M
    PETROFSKY, M
    YOUNG, LS
    [J]. INFECTION AND IMMUNITY, 1992, 60 (10) : 4245 - 4252
  • [9] Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines
    Boaventura, Viviane S.
    Santos, Claire S.
    Cardoso, Cristina R.
    de Andrade, Jose
    Dos Santos, Washington L. C.
    Clarencio, Jorge
    Silva, Joao S.
    Borges, Valeria M.
    Barral-Netto, Manoel
    Brodskyn, Claudia I.
    Barral, Aldina
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (10) : 2830 - 2836
  • [10] Carnaud C, 1999, J IMMUNOL, V163, P4647